Home › Therapeutic areas › Hematology › Immune Thrombocytopenia
Immune Thrombocytopenia (3 companies)
Companies with an active program in Immune Thrombocytopenia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals | HematologyMetabolic Rare | 1 | Approved | $1.76B | 7 |
| CLYM | Climb Bio | HematologyImmunology+1 Rare | 1 | Phase 2 | $604M | 8 |
| CGEM | Cullinan Therapeutics | HematologyImmunology+2 Rare | 1 | NDA Submitted | $728M | 10 |
No companies match.